Hunan Kelun Pharmaceutical Co., Ltd.

This is an early-stage study to check the safety of a new injectable drug called KLA318-2 in healthy people. Researchers will give the drug to 48 healthy volunteers and closely monitor them for any side effects. The main goal is to see how the body handles the drug and what dose …

This is the first study in humans to test a new drug called KLA478. It aims to check if the drug is safe and how the body absorbs and processes it. The study will involve 40 healthy volunteers who will receive a single dose. The main goal is to gather initial safety data and unde…